Cargando…

Comprehensive Analyses of Type 1 Diabetes Ketosis- or Ketoacidosis-Related Genes in Activated CD56(+)CD16(+) NK Cells

OBJECTIVES: Alterations in natural killer (NK) cells activity cause damage to pancreatic islets in type 1 diabetes mellitus (T1DM). The aim of this study is to identify T1DM ketosis- or ketoacidosis-related genes in activated CD56(+)CD16(+) NK cells. METHODS: Microarray datasets were downloaded from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Ruifeng, Dai, Fang, He, Yong, Sun, Li, Xu, Min, Deng, Datong, Zhang, Qiu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656236/ https://www.ncbi.nlm.nih.gov/pubmed/34899600 http://dx.doi.org/10.3389/fendo.2021.750135

Ejemplares similares

Integrative Analyses of Genes Associated With Osteoporosis in CD16+ Monocyte
por: Hu, Bin, et al.
Publicado: (2021)

Peripheral CD56(+)CD16(+) NK Cell Populations in the Early Follicular Phase Are Associated With Successful Clinical Outcomes of Intravenous Immunoglobulin Treatment in Women With Repeated Implantation Failure
por: Ho, Yao-Kai, et al.
Publicado: (2020)

Reduction of the CD16(−)CD56(bright) NK Cell Subset Precedes NK Cell Dysfunction in Prostate Cancer
por: Koo, Kyo Chul, et al.
Publicado: (2013)

CD56(dim)CD16(dim) Natural Killer (NK) Cells: The Forgotten Population
por: Zimmer, Jacques
Publicado: (2020)

The Increased Ratio of Blood CD56(bright) NK to CD56(dim) NK Is a Distinguishing Feature of Primary Sjögren's Syndrome
por: Ming, Bingxia, et al.
Publicado: (2020)

Loss of CCR7 Expression on CD56(bright) NK Cells Is Associated with a CD56(dim)CD16(+) NK Cell-Like Phenotype and Correlates with HIV Viral Load
por: Hong, Henoch S., et al.
Publicado: (2012)

CD56(neg)CD16(+) NK cells are activated mature NK cells with impaired effector function during HIV-1 infection
por: Milush, Jeffrey M, et al.
Publicado: (2013)

Functional TRPA1 Channels Regulate CD56(dim)CD16(+) NK Cell Cytotoxicity against Tumor Cells
por: Scopelliti, Fernanda, et al.
Publicado: (2023)

The frequencies of peripheral blood CD5(+)CD19(+) B cells, CD3(−)CD16(+)CD56(+) NK, and CD3(+)CD56(+) NKT cells and serum interleukin-10 in patients with multiple sclerosis and neuromyelitis optica spectrum disorder
por: Khani, Leila, et al.
Publicado: (2022)

A New Hope for CD56(neg)CD16(pos) NK Cells as Unconventional Cytotoxic Mediators: An Adaptation to Chronic Diseases
por: Forconi, Catherine S., et al.
Publicado: (2020)

Toll-like receptor 8 agonists improve NK-cell function primarily targeting CD56(bright)CD16(−) subset
por: Veneziani, Irene, et al.
Publicado: (2022)

Expansion of CD56(dim)CD16(neg) NK Cell Subset and Increased Inhibitory KIRs in Hospitalized COVID-19 Patients
por: Casado, José L., et al.
Publicado: (2021)

NK cells CD56(bright) and CD56(dim) subset cytokine loss and exhaustion is associated with impaired survival in myeloma
por: Seymour, Frances, et al.
Publicado: (2022)

CD56(dim)CD16(high) and CD56(bright)CD16(−) cell percentages associated with maximum knee extensor strength and incidence of death in elderly
por: Senpuku, Hidenobu, et al.
Publicado: (2016)

Oncolytic virus treatment differentially affects the CD56(dim) and CD56(bright) NK cell subsets in vivo and regulates a spectrum of human NK cell activity
por: Wantoch, Michelle, et al.
Publicado: (2022)

Distinguishing Human Peripheral Blood NK Cells from CD56(dim)CD16(dim)CD69(+)CD103(+) Resident Nasal Mucosal Lavage Fluid Cells
por: Rebuli, Meghan E., et al.
Publicado: (2018)

Euglycemic Diabetic Ketoacidosis Caused by Alcoholic Pancreatitis and Starvation Ketosis
por: Han, Hye Jeong, et al.
Publicado: (2023)

Correction: Toll-like reReceptor 8 agonists improve NK-cell function primarily targeting CD56(bright)CD16(−) subset
Publicado: (2022)

CD56 regulates human NK cell cytotoxicity through Pyk2
por: Gunesch, Justin T, et al.
Publicado: (2020)

ABCC3 Expressed by CD56(dim) CD16(+) NK Cells Predicts Response in Glioblastoma Patients Treated with Combined Chemotherapy and Dendritic Cell Immunotherapy
por: Pellegatta, Serena, et al.
Publicado: (2019)

Reduced frequency of cytotoxic CD56(dim) CD16(+) NK cells leads to impaired antibody-dependent degranulation in EBV-positive classical Hodgkin lymphoma
por: Pánisová, Elena, et al.
Publicado: (2021)

Ketosis-Prone Type 2 Diabetes: A Case Series
por: Sjöholm, Åke
Publicado: (2019)

CD4+CD56+ Lineage Negative Hematopoietic Neoplasm : So Called Blastic NK Cell Lymphoma
por: Kim, Yoonjung, et al.
Publicado: (2005)

Prolonged Ketosis in a Patient With Euglycemic Diabetic Ketoacidosis Secondary to Dapagliflozin
por: Pujara, Shreya, et al.
Publicado: (2017)

Redistribution and Activation of CD16brightCD56dim NK Cell Subset to Fight against Omicron Subvariant BA.2 after COVID-19 Vaccination
por: Peng, Huiyun, et al.
Publicado: (2023)

Ageing is associated with a decline in peripheral blood CD56(bright )NK cells
por: Chidrawar, Shivani M, et al.
Publicado: (2006)

Circulating CD56(bright) NK cells inversely correlate with survival of melanoma patients
por: de Jonge, Kaat, et al.
Publicado: (2019)

Identification and Functional Analysis of Human CD56(neg) NK Cells by Flow Cytometry
por: Orrantia, Ane, et al.
Publicado: (2020)

Alveolar Rhabdomyosarcoma with CD 56 Positivity: A Mimic of Extranodal NK/T Cell Lymphoma
por: Kumar, Uma, et al.
Publicado: (2022)

Regulation of Development of CD56(bright)CD11c(+) NK-like Cells with Helper Function by IL-18
por: Li, Wen, et al.
Publicado: (2013)

Expression of NK (CD16+56+) and B cells (CD19) Receptor Molecules as a Reliable Clinical Response Biomarkers of SLE and RA Patients Under the Rituximab Treatment
por: Zecevic, Lamija, et al.
Publicado: (2019)

Circulating NKG2A–NKG2D+ CD56dimCD16+ Natural Killer (NK) Cells as Mediators of Functional Immunosurveillance in Kidney Transplant Recipients
por: Zhu, Li, et al.
Publicado: (2020)

Alterations in the CD56(−) and CD56(+) T Cell Subsets during COVID-19
por: Vavilova, Julia D., et al.
Publicado: (2023)

The prevalence, hospitalization outcomes and risk factors of euthyroid sick syndrome in patients with diabetic ketosis/ketoacidosis
por: Deng, Xiao-yi, et al.
Publicado: (2023)

CD3, CD4, CD8, CD19 and CD16/CD56 positive cells in tuberculosis infection and disease: Peculiar features in children
por: Venturini, Elisabetta, et al.
Publicado: (2019)

AZD-1222: Hyperglycaemic ketosis, mixed hyperglycaemic hypermolar state/diabetic ketoacidosis and diabetic ketoacidosis: 3 case reports
Publicado: (2021)

Analysis of the Characteristics of TIGIT-Expressing CD3(−)CD56(+)NK Cells in Controlling Different Stages of HIV-1 Infection
por: Zhang, Xin, et al.
Publicado: (2021)

Primary CD56-positive NK/T-cell lymphoma of median nerve: a case report.
por: Kim, J., et al.
Publicado: (1998)

CD56-Negative Extranodal NK/T-Cell Lymphoma, Nasal Type, with Extranasal Cutaneous Involvement
por: Kim, Hee Joo, et al.
Publicado: (2015)

Human NK cell development requires CD56-mediated motility and formation of the developmental synapse
por: Mace, Emily M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jt6dn4655o0opp66kovmrrvnbi